Olverembatinib May Be Effective in Second Line for CP-CML
Olverembatinib showed potential in patients with chronic-phase chronic myeloid leukemia with prior exposure to first-line second-generation TKIs.
Related Articles
3 Things You Should Know About Immunotherapy in DLBCL
Here are 3 things you should know about immunotherapy in diffuse large B-cell lymphoma.
Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory Waldenstrom’s Macroglobulinemia
Fast track designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenstrom’s Macroglobulinemia…
Cancer in Africa | Cancer Epidemiology, Biomarkers & Prevention | American Association for Cancer Research
The burden of cancer is growing in Africa because of the aging and growth of the population, as well as the adoption of “westernized” lifestyles…
How Generational Status Affects Risk of Prostate Cancer in… : Oncology Times
An abstract is unavailable.
Fc Effector Function of Immune Checkpoint Blocking Antibodies in Oncology
Antagonistic monoclonal antibodies (mAbs) targeting inhibitory immune checkpoints have revolutionized the field of oncology. CTLA-4, PD-1, and LAG3 are three co-inhibitory receptors, which can be…
The Effect of Wearable Activity Monitors and Visual Feedback on Ambulation and Fitness in Patients Undergoing Transplantation | Oncology Nursing Society
Patients with multiple myeloma (MM) undergoing autologous stem cell transplantation (ASCT) are vulnerable to physical deconditioning while hospitalized (Kumar et al., 2020). The conditioning regimen,…
Blood Podcast | Blood | American Society of Hematology
Blood Podcast | Blood | American Society of Hematology Blood Podcast The editors of Blood are pleased to introduce a podcast series, published weekly…
#ASH24: Aggressive B-cell NHL
Catch up with our live social media coverage of aggressive B-NHL from the American Society of Hematology (ASH) 2024 Meeting and Exposition.
Prominent expansion of EBV+ large B cells obscuring follicular helper T-cell lymphoma
Leonard N. Yenwongfai, Ivo M. B. Francischetti; Prominent expansion of EBV + large B cells obscuring follicular helper T-cell lymphoma. Blood 2024; 144 (25): 2682.…
Fc Effector Function of Immune Checkpoint Blocking Antibodies in Oncology
Antagonistic monoclonal antibodies (mAbs) targeting inhibitory immune checkpoints have revolutionized the field of oncology. CTLA-4, PD-1, and LAG3 are three co-inhibitory receptors, which can be…